This project is part of a Blood and Marrow Transplant Clinical Research Network which is conducting multicenter clinical trials in hematopoietic stem cell transplantation. The purpose of the network is to promote the efficient comparison of novel treatment methods and management strategies of potential benefit for children and adults undergoing blood or marrow transplantation. Studies under development include a comparison of blood versus marrow stem cell transplantation. Studies under development include a comparison of blood versus marrow stem cell transplantation after marrow ablation, the development of non-myeloablative transplant regimens, and the best ways to avoid infections in transplant patients.
| Weisdorf, Daniel J (2010) How closely related is graft-vs-leukemia to donor/recipient disparity? Best Pract Res Clin Haematol 23:525-8 |
| Pavletic, Steven Z; Kumar, Shaji; Mohty, Mohamad et al. (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transpla Biol Blood Marrow Transplant 16:871-90 |
| Weisdorf, Daniel J; Nelson, Gene; Lee, Stephanie J et al. (2009) Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. Biol Blood Marrow Transplant 15:1475-8 |
| Reddy, Pavan; Arora, Mukta; Guimond, Martin et al. (2009) GVHD: a continuing barrier to the safety of allogeneic transplantation. Biol Blood Marrow Transplant 15:162-8 |
